Sonora Investment Management’s Arbutus Biopharma ABUS Stock Holding History

Sonora Investment Management’s Portfolio ABUS Stock Details ABUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-20	Closed	–	–	1249
2018 Q3	$0	Hold	20	–	–	﹤0.01%	1207
2018 Q2	$0	Hold	20	–	–	﹤0.01%	1170
2018 Q1	$100	Hold	20	–	–	﹤0.01%	1166
2017 Q4	$101	Hold	20	–	–	﹤0.01%	1175
2017 Q3	$124	Hold	20	–	–	﹤0.01%	1133
2017 Q2	$72	Hold	20	–	–	﹤0.01%	972
2017 Q1	$65	Hold	20	–	–	﹤0.01%	925
2016 Q4	$49	Hold	20	–	–	﹤0.01%	841
2016 Q3	$69	Hold	20	–	–	﹤0.01%	824
2016 Q2	$70	Hold	20	–	–	﹤0.01%	848
2016 Q1	$106	Hold	20	–	–	﹤0.01%	937
2015 Q4	$0	Hold	20	–	–	﹤0.01%	783
2015 Q3	$0	Buy	+20	New	+$177	﹤0.01%	1080

Other funds holding ABUS

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of Montreal

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Hudson Bay Capital Management

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return